HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Lymphotropic therapy with antitubercular agents in the treatment of tuberculous epididymitis].

Abstract
Whether endolymphatic intranodular injection (ELII) of isoniazid can be used in the combined treatment of male genital tuberculosis is considered. Clinical trials were performed and this method used in the combined treatment of tuberculous epididymitis was assessed. The bacteriostatic activity and blood and tissue concentration of the agent given as ELII were studied and compared with its intramuscular route of administration. The authors show it possible to employ scrotum ultrasound studies to evaluate the efficiency of treatment and estimate the scope of a surgical intervention. Based on the data of morphological study of postoperative specimens, the authors defined the time and worked out criteria for epididymectomy in tuberculous epididymitis.
AuthorsR V Gamazkov, R K Iagafarova, L A Ivanova
JournalProblemy tuberkuleza (Probl Tuberk) Issue 4 Pg. 21-4 ( 2001) ISSN: 0032-9533 [Print] Russia (Federation)
Vernacular TitleLimfotropnaia terapiia protivotuberkuleznymi preparatami pri lechenii tuberkuleznogo épididimita.
PMID11523363 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibiotics, Antitubercular
  • Antitubercular Agents
  • Ethambutol
  • Isoniazid
  • Rifampin
Topics
  • Adult
  • Antibiotics, Antitubercular (administration & dosage)
  • Antitubercular Agents (administration & dosage)
  • Epididymitis (diagnostic imaging, drug therapy, surgery)
  • Ethambutol (administration & dosage)
  • Humans
  • Injections, Intralymphatic
  • Injections, Intramuscular
  • Isoniazid (administration & dosage)
  • Male
  • Middle Aged
  • Rifampin (administration & dosage)
  • Tuberculosis, Male Genital (diagnostic imaging, drug therapy, surgery)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: